22 results
8-K
EX-99.1
BHVN
Biohaven Ltd.
15 Apr 24
Regulation FD Disclosure
6:59am
. BHV-1300 demonstrated faster IgG lowering in non-human primates DATAKEY APRIL 2024 ABI CONFERENCE 7
BHV-1300: UNIQUE PROPERTIES MATCHED TO CHRONIC
8-K
EX-99.1
BHVN
Biohaven Ltd.
8 Jan 24
Regulation FD Disclosure
7:30am
and epidemiological data show that interrupting chronic inflammation may slow disease progression ARIA Alzheimer’s Parkinson’s Multiple Sclerosis Other
8-K
EX-99.1
my1 1kvar
27 Sep 23
Regulation FD Disclosure
6:58am
8-K
EX-99.1
92f3nfmk2oq6x9n
31 Jul 23
Biohaven Reports Second Quarter 2023 Financial Results and Recent Business Developments
4:29pm
8-K
EX-99.1
o3f4tv 97
12 May 23
Biohaven Reports First Quarter 2023 Financial Results and Reports Recent Business Developments
4:47pm
10-Q
tl49xww
9 Nov 22
Quarterly report
4:19pm
424B4
7dt0eb0ybhod0dc
24 Oct 22
Prospectus supplement with pricing info
9:38am
S-1/A
7ooj3m 8it5d89etzvd
20 Oct 22
IPO registration (amended)
10:00am
S-1
kkjy olgvhsgs
18 Oct 22
IPO registration
4:03pm
DRS
3wbaz2vultwy7ih1n
11 Oct 22
Draft registration statement
12:00am
10-12B/A
EX-99.1
wa31s90
20 Sep 22
Registration of securities (amended)
6:30am
10-12B/A
EX-99.1
s23d73iujgprv
14 Sep 22
Registration of securities (amended)
5:25pm
10-12B/A
EX-99.1
zzbr6aiy
7 Sep 22
Registration of securities (amended)
7:26am
10-12B/A
EX-99.1
tnxb2mee ruymjis0xlb
24 Aug 22
Registration of securities (amended)
5:03pm